人源TNF-α抗体基因的克隆与表达(3)
 |
| 第1页 |
参见附件(1950KB，3页)。
[3]Tang S, Kang H, Zhu L, et al. Epidemiology investigation of allergic rhinitis in urban and rural areas of Ningbo and Yongzhou [J]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,2008,22(14):642-644.
[4]Wang Z. The effect of TNF-alpha & IL-8 in the pathogenesis of allergic rhinitis [J]. Lin Chuang Er Bi Yan Hou Ke Za Zhi,2006,20(23):1060-1061.
[5]Gorska-Ciebiada M, Ciebiada M, Gorska MM, et al. Intercellular adhesion molecule 1 and tumor necrosis factor alpha in asthma and persistent allergic rhinitis: relationship with disease severity [J]. Ann Allergy Asthma Immunol,2006,97(1):66-72.
[6]Masao L, Kuniaki S, Masao T, et al. TNF-α contributes to the development of allergic rhinitis in mice [J]. J Allergy Clin Immunol,2003,112(1):135-140.
[7]He J, Wang T, Yao LH, et al. Construction and delivery of gene therapy vector containing soluble TNF alpha receptor-IgG Fc fusion gene for the treatment of allergic rhinitis [J]. Cytokine,2006,36(5-6):296-304.
[8]González-Lama Y, López-San Román A, Marín-Jiménez I, et al. Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response [J]. Gastroenterol Hepatol,2008,31(7):421-426.
[9]Carbonell J, Badia X, grupo EXPRESAR. Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment [J]. Med Clin (Barc),2008,131(13):493-499.
[10]Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? [J]. Annu Rev Immunol,2001,19:163-196.
[11]Mease P. Infliximab (Remicade) in the treatment of psoriatic arthritis [J]. Ther Clin Risk Manag,2006,2(4):389-400.
[12]Bombardieri S, Ruiz AA, Fardellone P, et al. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice [J]. Rheumatology (Oxford),2007,46(7):1191-1199.
(收稿日期:2009-03-03)
您现在查看是摘要介绍页，详见PDF附件(1950KB，3页)。